The financial health and growth prospects of LZAGY, demonstrate its potential to underperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
When did Lonza go public?
21 October 2011
Does Novartis own Lonza?
Lonza will continue to employ the highly experienced team at the facility. The facility being acquired currently serves as the Novartis Center of Excellence for sterile clinical drug product manufacture. Lonza DPS launched three years ago and has expanded to meet customer demands, the company said.1 Jul 2019
What is Lonza known for?
Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We focus on enabling treatments that prevent illness and support healthier lifestyles. We optimize scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers.
Is Lonza a pharmaceutical company?
As the world's largest company for contract development and manufacturing, our Pharma Biotech & Nutrition segment is recognized for its reliable, high-quality services, regulatory track record, global footprint, innovative technology platforms and extensive experience.As the world's largest company for contract development and manufacturingcontract development and manufacturingA contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.https://en.wikipedia.org › Contract_manufacturing_organizationContract manufacturing organization - Wikipedia, our Pharma Biotech & Nutrition segment is recognized for its reliable, high-quality services, regulatory track record, global footprint, innovative technology platforms and extensive experience.
Who are Lonza competitors?
Lonza's top competitors include Bristol-Myers Squibb, Royal DSM, Catalent, DuPont, Novozymes, Divis Laboratories, WuXi Biologics, Nissan Chemical and Tokuyama.
Is Lonza a public company?
The Lonza shares are listed on the SIX Swiss Exchange and Swiss Market Index (SMI). We also maintain a secondary listing on the SGX Singapore Exchange.